buprenorphine and naloxone

FDA Drug Profile — Buprenorphine and Naloxone, BUPRENORPHINE AND NALOXONE, buprenorphine and naloxone

buprenorphine and naloxone is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including Buprenorphine and Naloxone, BUPRENORPHINE AND NALOXONE, buprenorphine and naloxone. Available dosage forms: film, film, soluble, tablet.

Drug details

Generic Name
buprenorphine and naloxone
Brand Names
Buprenorphine and Naloxone, BUPRENORPHINE AND NALOXONE, buprenorphine and naloxone
Application Number
ANDA212756
Sponsor
INGENUS PHARMACEUTICALS, LLC
NDC Codes
17
Dosage Forms
FILM, FILM, SOLUBLE, TABLET
Routes
BUCCAL, SUBLINGUAL
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual film is indicated for treatment of opioid dependence. Buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual film contains buprenorphine, a partial-opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual film should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.